The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development

References

• Davis JD, Wypych TP. Cellular and functional heterogeneity of the airway epithelium. Mucosal Immunol. 2021;14(5):978–990. doi:10.1038/s41385-020-00370-7
   PubMed Web of Science ®Google Scholar
• Basil MC, Katzen J, Engler AE, et al. The cellular and physiological basis for lung repair and regeneration: past, present, and future. Cell Stem Cell. 2020;26(4):482–502. doi:10.1016/j.stem.2020.03.009
   PubMed Web of Science ®Google Scholar
• Whitsett JA. Airway epithelial differentiation and mucociliary clearance. Ann Am Thorac Soc. 2018;15(Suppl 3):S143–S148. doi:10.1513/AnnalsATS.201802-128AW
   PubMed Web of Science ®Google Scholar
• Crystal RG, Randell SH, Engelhardt JF, Voynow J, Sunday ME. Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc. 2008;5(7):772–777. doi:10.1513/pats.200805-041HR
   PubMedGoogle Scholar
• Hellings PW, Steelant B. Epithelial barriers in allergy and asthma. J Allergy Clin Immunol. 2020;145(6):1499–1509. doi:10.1016/j.jaci.2020.04.010
   PubMed Web of Science ®Google Scholar
• Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology. 2003;8(4):432–446. doi:10.1046/j.1440-1843.2003.00493.x
   PubMed Web of Science ®Google Scholar
• Cereijido M, Contreras RG, Shoshani L. Cell adhesion, polarity, and epithelia in the Dawn of metazoans. Physiol Rev. 2004;84(4):1229–1262. doi:10.1152/physrev.00001.2004
   PubMed Web of Science ®Google Scholar
• Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17(9):564–580. doi:10.1038/nrm.2016.80
   PubMed Web of Science ®Google Scholar
• Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol. 2011;73:283–309. doi:10.1146/annurev-physiol-012110-142150
   PubMed Web of Science ®Google Scholar
• Steelant B, Seys SF, Boeckxstaens G, Akdis CA, Ceuppens JL, Hellings PW. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease. Rhinology. 2016;54(3):195–205. doi:10.4193/Rhino15.376
   PubMed Web of Science ®Google Scholar
• Otani T, Furuse M. Tight junction structure and function revisited: (trends in cell biology 30, 805–817, 2020). Trends Cell Biol. 2020;30(12):1014. doi:10.1016/j.tcb.2020.10.001
   PubMed Web of Science ®Google Scholar
• Raleigh DR, Marchiando AM, Zhang Y, et al. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell. 2010;21(7):1200–1213. doi:10.1091/mbc.e09-08-0734
   PubMed Web of Science ®Google Scholar
• Vermette D, Hu P, Canarie MF, Funaro M, Glover J, Pierce RW. Tight junction structure, function, and assessment in the critically ill: a systematic review. Intensive Care Med Exp. 2018;6(1):37. doi:10.1186/s40635-018-0203-4
   PubMed Web of Science ®Google Scholar
• Kast JI, Wanke K, Soyka MB, et al. The broad spectrum of interepithelial junctions in skin and lung. J Allergy Clin Immunol. 2012;130(2):544–547 e544. doi:10.1016/j.jaci.2012.04.044
   PubMed Web of Science ®Google Scholar
• Luissint AC, Nusrat A, Parkos CA. JAM-related proteins in mucosal homeostasis and inflammation. Semin Immunopathol. 2014;36(2):211–226. doi:10.1007/s00281-014-0421-0
   PubMed Web of Science ®Google Scholar
• Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A. 2001;98(26):15191–15196. doi:10.1073/pnas.261452898
   PubMed Web of Science ®Google Scholar
• Yuksel H, Turkeli A. Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood. Tissue Barriers. 2017;5(4):e1367458. doi:10.1080/21688370.2017.1367458
   PubMed Web of Science ®Google Scholar
• Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2(4):285–293. doi:10.1038/35067088
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol. 2003;4(3):225–236. doi:10.1038/nrm1055
   PubMed Web of Science ®Google Scholar
• Harris TJ, Tepass U. Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol. 2010;11(7):502–514. doi:10.1038/nrm2927
   PubMed Web of Science ®Google Scholar
• Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251(5000):1451–1455. doi:10.1126/science.2006419
   PubMed Web of Science ®Google Scholar
• Koval M. Sharing signals: connecting lung epithelial cells with gap junction channels. Am J Physiol Lung Cell Mol Physiol. 2002;283(5):L875–L893. doi:10.1152/ajplung.00078.2002
   PubMed Web of Science ®Google Scholar
• Johnson LN, Koval M. Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication. Antioxid Redox Signal. 2009;11(2):355–367. doi:10.1089/ars.2008.2183
   PubMed Web of Science ®Google Scholar
• Dubash AD, Green KJ. Desmosomes. Curr Biol. 2011;21(14):R529–531. doi:10.1016/j.cub.2011.04.035
   PubMed Web of Science ®Google Scholar
• Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim Biophys Acta. 2008;1778(3):572–587. doi:10.1016/j.bbamem.2007.07.014
   PubMed Web of Science ®Google Scholar
• Muller L, Hatzfeld M, Keil R. Desmosomes as signaling hubs in the regulation of cell behavior. Front Cell Dev Biol. 2021;9:745670. doi:10.3389/fcell.2021.745670
   PubMed Web of Science ®Google Scholar
• Rajasekaran AK, Hojo M, Huima T, Rodriguez-Boulan E. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J Cell Biol. 1996;132(3):451–463. doi:10.1083/jcb.132.3.451
   PubMed Web of Science ®Google Scholar
• Itoh M, Nagafuchi A, Moroi S, Tsukita S. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol. 1997;138(1):181–192. doi:10.1083/jcb.138.1.181
   PubMed Web of Science ®Google Scholar
• Reichert M, Muller T, Hunziker W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J Biol Chem. 2000;275(13):9492–9500. doi:10.1074/jbc.275.13.9492
   PubMed Web of Science ®Google Scholar
• Lewis JE, Wahl JK 3rd, Sass KM, Jensen PJ, Johnson KR, Wheelock MJ. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol. 1997;136(4):919–934. doi:10.1083/jcb.136.4.919
   PubMed Web of Science ®Google Scholar
• Tariq H, Bella J, Jowitt TA, et al. Cadherin flexibility provides a key difference between desmosomes and adherens junctions. Proc Natl Acad Sci U S A. 2015;112(17):5395–5400. doi:10.1073/pnas.1420508112
   PubMed Web of Science ®Google Scholar
• Herbert CA, King CM, Ring PC, et al. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol. 1995;12(4):369–378. doi:10.1165/ajrcmb.12.4.7695916
   PubMed Web of Science ®Google Scholar
• Matsumura Y. Role of allergen source-derived proteases in sensitization via airway epithelial cells. J Allergy. 2012;2012:903659. doi:10.1155/2012/903659
   PubMedGoogle Scholar
• Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest. 1999;104(1):123–133. doi:10.1172/JCI5844
   PubMed Web of Science ®Google Scholar
• Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol. 2008;8(3):193–204. doi:10.1038/nri2275
   PubMed Web of Science ®Google Scholar
• Looi K, Troy NM, Garratt LW, et al. Effect of human rhinovirus infection on airway epithelium tight junction protein disassembly and transepithelial permeability. Exp Lung Res. 2016;42(7):380–395. doi:10.1080/01902148.2016.1235237
   PubMed Web of Science ®Google Scholar
• Kast JI, McFarlane AJ, Globinska A, et al. Respiratory syncytial virus infection influences tight junction integrity. Clin Exp Immunol. 2017;190(3):351–359. doi:10.1111/cei.13042
   PubMed Web of Science ®Google Scholar
• Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21(11):739–751. doi:10.1038/s41577-021-00538-7
   PubMed Web of Science ®Google Scholar
• Heijink IH, Brandenburg SM, Postma DS, van Oosterhout AJ. Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur Respir J. 2012;39(2):419–428. doi:10.1183/09031936.00193810
   PubMed Web of Science ®Google Scholar
• Tamashiro E, Cohen NA, Palmer JN, Lima WT. Effects of cigarette smoking on the respiratory epithelium and its role in the pathogenesis of chronic rhinosinusitis. Braz J Otorhinolaryngol. 2009;75(6):903–907. doi:10.1016/s1808-8694(15)30557-7
   PubMedGoogle Scholar
• Schamberger AC, Staab-Weijnitz CA, Mise-Racek N, Eickelberg O. Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface. Sci Rep. 2015;5:8163. doi:10.1038/srep08163
   PubMed Web of Science ®Google Scholar
• Sokolowska M, Quesniaux VFJ, Akdis CA, Chung KF, Ryffel B, Togbe D. Acute respiratory barrier disruption by ozone exposure in mice. Front Immunol. 2019;10:2169. doi:10.3389/fimmu.2019.02169
   PubMed Web of Science ®Google Scholar
• Bromberg PA, Ranga V, Stutts MJ. Effects of ozone on airway epithelial permeability and ion transport. Res Rep Health Eff Inst. 1991;1991(48):1–22;discussion 23–32.
   Google Scholar
• Schamberger AC, Mise N, Jia J, et al. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-beta. Am J Respir Cell Mol Biol. 2014;50(6):1040–1052. doi:10.1165/rcmb.2013-0090OC
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kan OK, Tatsuta M, et al. Incense smoke-induced oxidative stress disrupts tight junctions and bronchial epithelial barrier integrity and induces airway hyperresponsiveness in mouse lungs. Sci Rep. 2021;11(1):7222. doi:10.1038/s41598-021-86745-7
   PubMed Web of Science ®Google Scholar
• Cao X, Lin H, Muskhelishvili L, Latendresse J, Richter P, Heflich RH. Tight junction disruption by cadmium in an in vitro human airway tissue model. Respir Res. 2015;16:30. doi:10.1186/s12931-015-0191-9
   PubMed Web of Science ®Google Scholar
• Cullinan P, Harris JM, Newman Taylor AJ, et al. An outbreak of asthma in a modern detergent factory. Lancet. 2000;356(9245):1899–1900. doi:10.1016/S0140-6736(00)03264-5
   PubMed Web of Science ®Google Scholar
• Hole AM, Draper A, Jolliffe G, Cullinan P, Jones M, Taylor AJ. Occupational asthma caused by bacillary amylase used in the detergent industry. Occup Environ Med. 2000;57(12):840–842. doi:10.1136/oem.57.12.840
   PubMed Web of Science ®Google Scholar
• Xian M, Wawrzyniak P, Ruckert B, et al. Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes. J Allergy Clin Immunol. 2016;138(3):890–893 e899. doi:10.1016/j.jaci.2016.07.003
   PubMed Web of Science ®Google Scholar
• Wang M, Tan G, Eljaszewicz A, et al. Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019;143(5):1892–1903. doi:10.1016/j.jaci.2018.11.016
   PubMed Web of Science ®Google Scholar
• Schleimer RP, Berdnikovs S. Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases. J Allergy Clin Immunol. 2017;139(6):1752–1761. doi:10.1016/j.jaci.2017.04.010
   PubMed Web of Science ®Google Scholar
• Heijink IH, Kuchibhotla VNS, Roffel MP, et al. Epithelial cell dysfunction, a major driver of asthma development. Allergy. 2020;75(8):1902–1917. doi:10.1111/all.14421
   PubMed Web of Science ®Google Scholar
• Hackett TL, Singhera GK, Shaheen F, et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution. Am J Respir Cell Mol Biol. 2011;45(5):1090–1100. doi:10.1165/rcmb.2011-0031OC
   PubMed Web of Science ®Google Scholar
• Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol. 2012;130(5):1087–1096 e1010. doi:10.1016/j.jaci.2012.05.052
   PubMed Web of Science ®Google Scholar
• Wawrzyniak P, Wawrzyniak M, Wanke K, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139(1):93–103. doi:10.1016/j.jaci.2016.03.050
   PubMed Web of Science ®Google Scholar
• Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128(3):549–556 e541–512. doi:10.1016/j.jaci.2011.05.038
   PubMed Web of Science ®Google Scholar
• Blume C, Swindle EJ, Dennison P, et al. Barrier responses of human bronchial epithelial cells to grass pollen exposure. Eur Respir J. 2013;42(1):87–97. doi:10.1183/09031936.00075612
   PubMed Web of Science ®Google Scholar
• de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol. 2008;86(3):105–112. doi:10.1139/Y08-004
   PubMed Web of Science ®Google Scholar
• Hackett TL, de Bruin HG, Shaheen F, et al. Caveolin-1 controls airway epithelial barrier function. Implications for asthma. Am J Respir Cell Mol Biol. 2013;49(4):662–671. doi:10.1165/rcmb.2013-0124OC
   PubMed Web of Science ®Google Scholar
• Steelant B, Farre R, Wawrzyniak P, et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. J Allergy Clin Immunol. 2016;137(4):1043–1053 e1045. doi:10.1016/j.jaci.2015.10.050
   PubMed Web of Science ®Google Scholar
• Sweerus K, Lachowicz-Scroggins M, Gordon E, et al. Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma. J Allergy Clin Immunol. 2017;139(1):72–81 e71. doi:10.1016/j.jaci.2016.02.035
   PubMed Web of Science ®Google Scholar
• Hackett TL. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol. 2012;12(1):53–59. doi:10.1097/ACI.0b013e32834ec6eb
   PubMed Web of Science ®Google Scholar
• Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341–352. doi:10.1038/s41580-020-0237-9
   PubMed Web of Science ®Google Scholar
• John M. Eisenberg Center for Clinical Decisions and Communications Science. Omega-3 fatty acids and cardiovascular disease: a review of the research for adults. In: Comparative Effectiveness Review Summary Guides for Consumers. Rockville (MD): Agency for Healthcare Research and Quality; 2005.
   Google Scholar
• Reuter S, Martin H, Beckert H, et al. The Wnt/beta-catenin pathway attenuates experimental allergic airway disease. J Immunol. 2014;193(2):485–495. doi:10.4049/jimmunol.1400013
   PubMed Web of Science ®Google Scholar
• Yao L, Zhao H, Tang H, et al. Blockade of beta-catenin signaling attenuates toluene diisocyanate-induced experimental asthma. Allergy. 2017;72(4):579–589. doi:10.1111/all.13045
   PubMed Web of Science ®Google Scholar
• Vroling AB, Fokkens WJ, van Drunen CM. How epithelial cells detect danger: aiding the immune response. Allergy. 2008;63(9):1110–1123. doi:10.1111/j.1398-9995.2008.01785.x
   PubMed Web of Science ®Google Scholar
• Wills-Karp M. Allergen-specific pattern recognition receptor pathways. Curr Opin Immunol. 2010;22(6):777–782. doi:10.1016/j.coi.2010.10.011
   PubMed Web of Science ®Google Scholar
• Laulajainen-Hongisto A, Toppila-Salmi SK, Luukkainen A, Kern R. Airway epithelial dynamics in allergy and related chronic inflammatory airway diseases. Front Cell Dev Biol. 2020;8:204. doi:10.3389/fcell.2020.00204
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118(11):3546–3556. doi:10.1172/JCI36130
   PubMed Web of Science ®Google Scholar
• Kaur K, Bachus H, Lewis C, et al. GM-CSF production by non-classical monocytes controls antagonistic LPS-driven functions in allergic inflammation. Cell Rep. 2021;37(13):110178. doi:10.1016/j.celrep.2021.110178
   PubMed Web of Science ®Google Scholar
• Hamilton LM, Torres-Lozano C, Puddicombe SM, et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy. 2003;33(2):233–240. doi:10.1046/j.1365-2222.2003.01593.x
   PubMed Web of Science ®Google Scholar
• Bayarri MA, Milara J, Estornut C, Cortijo J. Nitric oxide system and bronchial epithelium: more than a barrier. Front Physiol. 2021;12:687381. doi:10.3389/fphys.2021.687381
   PubMed Web of Science ®Google Scholar
• Hardiman KM, McNicholas-Bevensee CM, Fortenberry J, et al. Regulation of amiloride-sensitive Na(+) transport by basal nitric oxide. Am J Respir Cell Mol Biol. 2004;30(5):720–728. doi:10.1165/rcmb.2003-0325OC
   PubMed Web of Science ®Google Scholar
• Olson N, Greul AK, Hristova M, Bove PF, Kasahara DI, van der Vliet A. Nitric oxide and airway epithelial barrier function: regulation of tight junction proteins and epithelial permeability. Arch Biochem Biophys. 2009;484(2):205–213. doi:10.1016/j.abb.2008.11.027
   PubMed Web of Science ®Google Scholar
• Burgstaller G, Oehrle B, Gerckens M, White ES, Schiller HB, Eickelberg O. The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease. Eur Respir J. 2017;50(1):1601805.
   PubMed Web of Science ®Google Scholar
• Lee CG, Ma B, Takyar S, et al. Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011;8(6):512–515. doi:10.1513/pats.201102-018MW
   PubMedGoogle Scholar
• Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol. 2010;10(12):838–848. doi:10.1038/nri2870
   PubMed Web of Science ®Google Scholar
• Wu CA, Peluso JJ, Zhu L, Lingenheld EG, Walker ST, Puddington L. Bronchial epithelial cells produce IL-5: implications for local immune responses in the airways. Cell Immunol. 2010;264(1):32–41. doi:10.1016/j.cellimm.2010.04.008
   PubMed Web of Science ®Google Scholar
• Martinez FD, Vercelli D. Asthma. Lancet. 2013;382(9901):1360–1372. doi:10.1016/S0140-6736(13)61536-6
   PubMed Web of Science ®Google Scholar
• Kau AL, Korenblat PE. Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes. Curr Opin Allergy Clin Immunol. 2014;14(6):570–575. doi:10.1097/ACI.0000000000000108
   PubMed Web of Science ®Google Scholar
• Sugita K, Steer CA, Martinez-Gonzalez I, et al. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):300–310 e311. doi:10.1016/j.jaci.2017.02.038
   PubMed Web of Science ®Google Scholar
• Tan HT, Hagner S, Ruchti F, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2019;74(2):294–307. doi:10.1111/all.13619
   PubMed Web of Science ®Google Scholar
• Major J, Crotta S, Llorian M, et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science. 2020;369(6504):712–717. doi:10.1126/science.abc2061
   PubMed Web of Science ®Google Scholar
• Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell. 2002;13(9):3218–3234. doi:10.1091/mbc.e02-03-0134
   PubMed Web of Science ®Google Scholar
• Hardyman MA, Wilkinson E, Martin E, et al. TNF-alpha-mediated bronchial barrier disruption and regulation by src-family kinase activation. J Allergy Clin Immunol. 2013;132(3):665–675 e668. doi:10.1016/j.jaci.2013.03.005
   PubMed Web of Science ®Google Scholar
• Zabner J, Winter MC, Shasby S, Ries D, Shasby DM. Histamine decreases E-cadherin-based adhesion to increase permeability of human airway epithelium. Chest. 2003;123(3 Suppl):385S. doi:10.1378/chest.123.3_suppl.385S
   PubMed Web of Science ®Google Scholar
• Zabner J, Winter M, Excoffon KJ, et al. Histamine alters E-cadherin cell adhesion to increase human airway epithelial permeability. J Appl Physiol. 2003;95(1):394–401. doi:10.1152/japplphysiol.01134.2002
   PubMed Web of Science ®Google Scholar
• Sanak M. Eicosanoid mediators in the airway inflammation of asthmatic patients: what is new? Allergy Asthma Immunol Res. 2016;8(6):481–490. doi:10.4168/aair.2016.8.6.481
   PubMed Web of Science ®Google Scholar
• Luster AD, Tager AM. T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol. 2004;4(9):711–724. doi:10.1038/nri1438
   PubMed Web of Science ®Google Scholar
• Liu MC, Bleecker ER, Lichtenstein LM, et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis. 1990;142(1):126–132. doi:10.1164/ajrccm/142.1.126
   PubMed Web of Science ®Google Scholar
• Liu MC, Proud D, Lichtenstein LM, et al. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol. 2001;108(1):29–38. doi:10.1067/mai.2001.116004
   PubMed Web of Science ®Google Scholar
• Alving K, Matran R, Lundberg JM. The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. Acta Physiol Scand. 1991;143(1):93–103. doi:10.1111/j.1748-1716.1991.tb09204.x
   PubMedGoogle Scholar
• Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science. 2000;287(5460):2013–2017. doi:10.1126/science.287.5460.2013
   PubMed Web of Science ®Google Scholar
• Mondino C, Ciabattoni G, Koch P, et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol. 2004;114(4):761–767. doi:10.1016/j.jaci.2004.06.054
   PubMed Web of Science ®Google Scholar
• Pavord ID, Ward R, Woltmann G, Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med. 1999;160(6):1905–1909. doi:10.1164/ajrccm.160.6.9903114
   PubMed Web of Science ®Google Scholar
• Tager AM, Bromley SK, Medoff BD, et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol. 2003;4(10):982–990. doi:10.1038/ni970
   PubMed Web of Science ®Google Scholar
• Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol. 2003;4(10):965–973. doi:10.1038/ni972
   PubMed Web of Science ®Google Scholar
• Snyder F. Platelet-activating factor: the biosynthetic and catabolic enzymes. Biochem J. 1995;305(Pt 3):689–705. doi:10.1042/bj3050689
   PubMed Web of Science ®Google Scholar
• Schauberger E, Peinhaupt M, Cazares T, Lindsley AW. Lipid mediators of allergic disease: pathways, treatments, and emerging therapeutic targets. Curr Allergy Asthma Rep. 2016;16(7):48. doi:10.1007/s11882-016-0628-3
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy N, Abdulnour RE, Walker KH, Engstrom BD, Levy BD. Specialized proresolving mediators in innate and adaptive immune responses in airway diseases. Physiol Rev. 2018;98(3):1335–1370. doi:10.1152/physrev.00026.2017
   PubMed Web of Science ®Google Scholar
• Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191–1197. doi:10.1038/ni1276
   PubMed Web of Science ®Google Scholar
• Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40(3):315–327. doi:10.1016/j.immuni.2014.02.009
   PubMed Web of Science ®Google Scholar
• Levy BD, Bonnans C, Silverman ES, et al. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med. 2005;172(7):824–830. doi:10.1164/rccm.200410-1413OC
   PubMed Web of Science ®Google Scholar
• Vachier I, Bonnans C, Chavis C, et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol. 2005;115(1):55–60. doi:10.1016/j.jaci.2004.09.038
   PubMed Web of Science ®Google Scholar
• Ono E, Dutile S, Kazani S, et al. Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. Am J Respir Crit Care Med. 2014;190(8):886–897. doi:10.1164/rccm.201403-0544OC
   PubMed Web of Science ®Google Scholar
• Christie PE, Spur BW, Lee TH. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis. 1992;145(6):1281–1284. doi:10.1164/ajrccm/145.6.1281
   PubMed Web of Science ®Google Scholar
• Kong X, Wu SH, Zhang L, Chen XQ. Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes. Exp Ther Med. 2017;14(3):2284–2290. doi:10.3892/etm.2017.4787
   PubMed Web of Science ®Google Scholar
• Steinke JW, Liu L, Huyett P, Negri J, Payne SC, Borish L. Prominent role of IFN-gamma in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2013;132(4):856–865 e851–853. doi:10.1016/j.jaci.2013.05.008
   PubMed Web of Science ®Google Scholar
• Soyombo O, Spur BW, Lee TH. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy. 1994;49(4):230–234. doi:10.1111/j.1398-9995.1994.tb02654.x
   PubMed Web of Science ®Google Scholar
• Planaguma A, Kazani S, Marigowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med. 2008;178(6):574–582. doi:10.1164/rccm.200801-061OC
   PubMed Web of Science ®Google Scholar
• Bonnans C, Fukunaga K, Levy MA, Levy BD. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am J Pathol. 2006;168(4):1064–1072. doi:10.2353/ajpath.2006.051056
   PubMed Web of Science ®Google Scholar
• Barnig C, Cernadas M, Dutile S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med. 2013;5(174):174ra126. doi:10.1126/scitranslmed.3004812
   Web of Science ®Google Scholar
• Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol. 2008;9(8):873–879. doi:10.1038/ni.1627
   PubMed Web of Science ®Google Scholar
• Aoki H, Hisada T, Ishizuka T, et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun. 2008;367(2):509–515. doi:10.1016/j.bbrc.2008.01.012
   PubMed Web of Science ®Google Scholar
• Rogerio AP, Haworth O, Croze R, et al. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol. 2012;189(4):1983–1991. doi:10.4049/jimmunol.1101665
   PubMed Web of Science ®Google Scholar
• Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol. 2007;178(1):496–502. doi:10.4049/jimmunol.178.1.496
   PubMed Web of Science ®Google Scholar
• Lin YJ, Flaczyk A, Wolfheimer S, et al. The fusion protein rFlaA:Betv1 modulates DC responses by a p38-MAPK and COX2-dependent secretion of PGE2 from epithelial cells. Cells. 2021;10:12. doi:10.3390/cells10123415
   Web of Science ®Google Scholar
• Zhou Y, Wang W, Zhao C, et al. Prostaglandin E2 inhibits group 2 innate lymphoid cell activation and allergic airway inflammation through E-prostanoid 4-cyclic adenosine monophosphate signaling. Front Immunol. 2018;9:501. doi:10.3389/fimmu.2018.00501
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Moodley YP, Thompson PJ, Misso NL. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation. Clin Exp Allergy. 2010;40(1):85–93. doi:10.1111/j.1365-2222.2009.03386.x
   PubMed Web of Science ®Google Scholar
• Pavord ID, Wong CS, Williams J, Tattersfield AE. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis. 1993;148(1):87–90. doi:10.1164/ajrccm/148.1.87
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Tokuoka S, Masuda T, et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol. 2002;137(3):315–322. doi:10.1038/sj.bjp.0704872
   PubMed Web of Science ®Google Scholar
• Nagao K, Tanaka H, Komai M, Masuda T, Narumiya S, Nagai H. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol. 2003;29(3pt 1):314–320. doi:10.1165/rcmb.2003-0035OC
   PubMed Web of Science ®Google Scholar
• Yamabayashi C, Koya T, Kagamu H, et al. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice. Am J Respir Cell Mol Biol. 2012;47(2):170–177. doi:10.1165/rcmb.2011-0350OC
   PubMed Web of Science ®Google Scholar
• Tripathi P, Awasthi S, Husain N, Prasad R, Mishra V. Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls. Indian J Med Res. 2013;137(3):507–514.
   PubMedGoogle Scholar
• Biswas S. Role of PCDH 1 gene in the development of childhood asthma and other related phenotypes: a literature review. Cureus. 2018;10(9):e3360. doi:10.7759/cureus.3360
   PubMedGoogle Scholar
• Koppelman GH, Meyers DA, Howard TD, et al. Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2009;180(10):929–935. doi:10.1164/rccm.200810-1621OC
   PubMed Web of Science ®Google Scholar
• Bonnelykke K, Coleman AT, Evans MD, et al. Cadherin-related family member 3 genetics and rhinovirus C respiratory illnesses. Am J Respir Crit Care Med. 2018;197(5):589–594. doi:10.1164/rccm.201705-1021OC
   PubMed Web of Science ®Google Scholar
• Everman JL, Sajuthi S, Saef B, et al. Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations. J Allergy Clin Immunol. 2019;144(4):962–971. doi:10.1016/j.jaci.2019.01.052
   PubMed Web of Science ®Google Scholar
• Chung LP, Baltic S, Ferreira M, Temple S, Waterer G, Thompson PJ. Beta2 adrenergic receptor (ADRbeta2) haplotype pair (2/4) is associated with severe asthma. PLoS One. 2014;9(4):e93695. doi:10.1371/journal.pone.0093695
   PubMed Web of Science ®Google Scholar
• Biagini Myers JM, Martin LJ, Kovacic MB, et al. Epistasis between serine protease inhibitor Kazal-type 5 (SPINK5) and thymic stromal lymphopoietin (TSLP) genes contributes to childhood asthma. J Allergy Clin Immunol. 2014;134(4):891–899 e893. doi:10.1016/j.jaci.2014.03.037
   PubMed Web of Science ®Google Scholar
• Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–1221. doi:10.1056/NEJMoa0906312
   PubMed Web of Science ®Google Scholar
• Saikumar Jayalatha AK, Hesse L, Ketelaar ME, Koppelman GH, Nawijn MC. The central role of IL-33/IL-1RL1 pathway in asthma: from pathogenesis to intervention. Pharmacol Ther. 2021;225:107847. doi:10.1016/j.pharmthera.2021.107847
   PubMed Web of Science ®Google Scholar
• Gordon ED, Palandra J, Wesolowska-Andersen A, et al. IL1RL1 asthma risk variants regulate airway type 2 inflammation. JCI Insight. 2016;1(14):e87871. doi:10.1172/jci.insight.87871
   PubMed Web of Science ®Google Scholar
• Yang R, Tan M, Xu J, Zhao X. Investigating the regulatory role of ORMDL3 in airway barrier dysfunction using in vivo and in vitro models. Int J Mol Med. 2019;44(2):535–548. doi:10.3892/ijmm.2019.4233
   PubMed Web of Science ®Google Scholar
• James B, Milstien S, Spiegel S. ORMDL3 and allergic asthma: from physiology to pathology. J Allergy Clin Immunol. 2019;144(3):634–640. doi:10.1016/j.jaci.2019.07.023
   PubMed Web of Science ®Google Scholar
• Laura G, Liu Y, Fernandes K, et al. ORMDL3 regulates poly I:C induced inflammatory responses in airway epithelial cells. BMC Pulm Med. 2021;21(1):167. doi:10.1186/s12890-021-01496-5
   PubMed Web of Science ®Google Scholar
• Zhang YM. Orosomucoid-like protein 3, rhinovirus and asthma. World J Crit Care Med. 2021;10(5):170–182. doi:10.5492/wjccm.v10.i5.170
   PubMedGoogle Scholar
• Liu Y, Bochkov YA, Eickhoff JC, et al. Orosomucoid-like 3 supports rhinovirus replication in human epithelial cells. Am J Respir Cell Mol Biol. 2020;62(6):783–792. doi:10.1165/rcmb.2019-0237OC
   PubMed Web of Science ®Google Scholar
• Yu F, Sun Y, Yu J, et al. ORMDL3 is associated with airway remodeling in asthma via the ERK/MMP-9 pathway. Mol Med Rep. 2017;15(5):2969–2976. doi:10.3892/mmr.2017.6413
   PubMed Web of Science ®Google Scholar
• Anthoni M, Wang G, Leino MS, Lauerma AI, Alenius HT, Wolff HJ. Smad3 -signalling and Th2 cytokines in normal mouse airways and in a mouse model of asthma. Int J Biol Sci. 2007;3(7):477–485. doi:10.7150/ijbs.3.477
   PubMed Web of Science ®Google Scholar
• Fan Q, Jian Y. MiR-203a-3p regulates TGF-beta1-induced epithelial-mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1. Biosci Rep. 2020;40:2. doi:10.1042/BSR20192645
   Web of Science ®Google Scholar
• Lund RJ, Osmala M, Malonzo M, et al. Atopic asthma after rhinovirus-induced wheezing is associated with DNA methylation change in the SMAD3 gene promoter. Allergy. 2018;73(8):1735–1740. doi:10.1111/all.13473
   PubMed Web of Science ®Google Scholar
• Gibbs JD, Ornoff DM, Igo HA, Zeng JY, Imani F. Cell cycle arrest by transforming growth factor beta1 enhances replication of respiratory syncytial virus in lung epithelial cells. J Virol. 2009;83(23):12424–12431. doi:10.1128/JVI.00806-09
   PubMed Web of Science ®Google Scholar
• Werder RB, Ullah MA, Rahman MM, et al. Targeting the P2Y13 receptor suppresses IL-33 and HMGB1 release and ameliorates experimental asthma. Am J Respir Crit Care Med. 2022;205(3):300–312. doi:10.1164/rccm.202009-3686OC
   PubMed Web of Science ®Google Scholar
• Sordillo JE, Kelly R, Bunyavanich S, et al. Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity. J Allergy Clin Immunol. 2015;136(4):885–892 e882. doi:10.1016/j.jaci.2015.02.035
   PubMed Web of Science ®Google Scholar
• Alashkar Alhamwe B, Miethe S, Pogge von Strandmann E, Potaczek DP, Garn H. Epigenetic regulation of airway epithelium immune functions in asthma. Front Immunol. 2020;11:1747. doi:10.3389/fimmu.2020.01747
   PubMed Web of Science ®Google Scholar
• Sugita K, Soyka MB, Wawrzyniak P, et al. Outside-in hypothesis revisited: the role of microbial, epithelial, and immune interactions. Ann Allergy Asthma Immunol. 2020;125(5):517–527. doi:10.1016/j.anai.2020.05.016
   PubMed Web of Science ®Google Scholar
• Lee AY. The role of microRNAs in epidermal barrier. Int J Mol Sci. 2020;21:16.
   Web of Science ®Google Scholar
• Potaczek DP, Harb H, Michel S, Alhamwe BA, Renz H, Tost J. Epigenetics and allergy: from basic mechanisms to clinical applications. Epigenomics. 2017;9(4):539–571. doi:10.2217/epi-2016-0162
   PubMed Web of Science ®Google Scholar
• Kabesch M, Tost J. Recent findings in the genetics and epigenetics of asthma and allergy. Semin Immunopathol. 2020;42(1):43–60. doi:10.1007/s00281-019-00777-w
   PubMed Web of Science ®Google Scholar
• Wang CM, Chang CB, Wu SF. Differential DNA methylation in allergen-specific immunotherapy of asthma. Cell Mol Immunol. 2020;17(9):1017–1018. doi:10.1038/s41423-020-0476-x
   PubMed Web of Science ®Google Scholar
• Wawrzyniak P, Krawczyk K, Acharya S, et al. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma. Allergy. 2021;76(6):1864–1868. doi:10.1111/all.14667
   PubMed Web of Science ®Google Scholar
• Vermeulen CJ, Xu CJ, Vonk JM, et al. Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission. Eur Respir J. 2020;55:2. doi:10.1183/13993003.01280-2019
   Web of Science ®Google Scholar
• Cardenas A, Fadadu RP, Van Der Laan L, et al. Controlled human exposures to diesel exhaust: a human epigenome-wide experiment of target bronchial epithelial cells. Environ Epigenet. 2021;7(1):dvab003. doi:10.1093/eep/dvab003
   PubMed Web of Science ®Google Scholar
• Qin W, Brands X, Van’t Veer C, et al. Bronchial epithelial DNA methyltransferase 3b dampens pulmonary immune responses during Pseudomonas aeruginosa infection. PLoS Pathog. 2021;17(4):e1009491. doi:10.1371/journal.ppat.1009491
   PubMed Web of Science ®Google Scholar
• Liberti DC, Zepp JA, Bartoni CA, et al. Dnmt1 is required for proximal-distal patterning of the lung endoderm and for restraining alveolar type 2 cell fate. Dev Biol. 2019;454(2):108–117. doi:10.1016/j.ydbio.2019.06.019
   PubMed Web of Science ®Google Scholar
• Lawlor L, Yang XB. Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering. Int J Oral Sci. 2019;11(2):20. doi:10.1038/s41368-019-0053-2
   PubMed Web of Science ®Google Scholar
• Steelant B, Wawrzyniak P, Martens K, et al. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis. J Allergy Clin Immunol. 2019;144(5):1242–1253 e1247. doi:10.1016/j.jaci.2019.04.027
   PubMed Web of Science ®Google Scholar
• Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 2006;203(1):7–13. doi:10.1084/jem.20050466
   PubMed Web of Science ®Google Scholar
• Wei W, Chen W, He N. HDAC4 induces the development of asthma by increasing Slug-upregulated CXCL12 expression through KLF5 deacetylation. J Transl Med. 2021;19(1):258. doi:10.1186/s12967-021-02812-7
   PubMed Web of Science ®Google Scholar
• Ren Y, Su X, Kong L, et al. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model. Inflamm Res. 2016;65(12):995–1008. doi:10.1007/s00011-016-0984-4
   PubMed Web of Science ®Google Scholar
• Wang J, Cui M, Sun F, et al. HDAC inhibitor sodium butyrate prevents allergic rhinitis and alters lncRNA and mRNA expression profiles in the nasal mucosa of mice. Int J Mol Med. 2020;45(4):1150–1162. doi:10.3892/ijmm.2020.4489
   PubMed Web of Science ®Google Scholar
• Sekiyama A, Gon Y, Terakado M, et al. Glucocorticoids enhance airway epithelial barrier integrity. Int Immunopharmacol. 2012;12(2):350–357. doi:10.1016/j.intimp.2011.12.006
   PubMed Web of Science ®Google Scholar
• Rimmer C, Hetelekides S, Eliseeva SI, Georas SN, Veazey JM, Deli MA. Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge. PLoS One. 2021;16(12):e0260706. doi:10.1371/journal.pone.0260706
   PubMed Web of Science ®Google Scholar
• Ma S, Xian M, Wang Y, Wang C, Zhang L. Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM2.5. Clin Transl Allergy. 2021;11(5):e12019. doi:10.1002/clt2.12029
   PubMed Web of Science ®Google Scholar
• Doulaptsi M, Wils T, Hellings PW, et al. Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis. World Allergy Organ J. 2021;14(9):100585. doi:10.1016/j.waojou.2021.100585
   PubMed Web of Science ®Google Scholar
• Qian J, Xu Y, Yu Z. Budesonide and calcitriol synergistically inhibit airway remodeling in asthmatic mice. Can Respir J. 2018;2018:5259240. doi:10.1155/2018/5259240
   PubMed Web of Science ®Google Scholar
• Southam DS, Ellis R, Wattie J, Young S, Inman MD. Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice. Eur Respir J. 2008;32(4):970–978. doi:10.1183/09031936.00125307
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med. 2004;170(8):836–844. doi:10.1164/rccm.200401-033OC
   PubMed Web of Science ®Google Scholar
• Kardas G, Kuna P, Panek M. Biological therapies of severe asthma and their possible effects on airway remodeling. Front Immunol. 2020;11:1134. doi:10.3389/fimmu.2020.01134
   PubMed Web of Science ®Google Scholar
• Riccio AM, Dal Negro RW, Micheletto C, et al. Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. Int J Immunopathol Pharmacol. 2012;25(2):475–484. doi:10.1177/039463201202500217
   PubMed Web of Science ®Google Scholar
• Zastrzezynska W, Przybyszowski M, Bazan-Socha S, et al. Omalizumab may decrease the thickness of the reticular basement membrane and fibronectin deposit in the bronchial mucosa of severe allergic asthmatics. J Asthma. 2020;57(5):468–477. doi:10.1080/02770903.2019.1585872
   PubMed Web of Science ®Google Scholar
• Hoshino M, Ohtawa J. Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma. Respiration. 2012;83(6):520–528. doi:10.1159/000334701
   PubMed Web of Science ®Google Scholar
• Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol. 2013;132(5):1086–1096 e1085. doi:10.1016/j.jaci.2013.05.020
   PubMed Web of Science ®Google Scholar
• Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW. A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma. Int Arch Allergy Immunol. 2016;170(2):122–131. doi:10.1159/000447692
   PubMed Web of Science ®Google Scholar
• Turkeli A, Yilmaz O, Karaman M, et al. Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models. Exp Ther Med. 2021;22(1):689. doi:10.3892/etm.2021.10121
   PubMed Web of Science ®Google Scholar
• Globinska A, Boonpiyathad T, Satitsuksanoa P, et al. Mechanisms of allergen-specific immunotherapy: diverse mechanisms of immune tolerance to allergens. Ann Allergy Asthma Immunol. 2018;121(3):306–312. doi:10.1016/j.anai.2018.06.026
   PubMed Web of Science ®Google Scholar
• Shamji MH, Layhadi JA, Sharif H, Penagos M, Durham SR. Immunological responses and biomarkers for allergen-specific immunotherapy against inhaled allergens. J Allergy Clin Immunol Pract. 2021;9(5):1769–1778. doi:10.1016/j.jaip.2021.03.029
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011;127(1):18–27; quiz 28–19. doi:10.1016/j.jaci.2010.11.030
   Web of Science ®Google Scholar
• Yuan X, Wang J, Li Y, et al. Allergy immunotherapy restores airway epithelial barrier dysfunction through suppressing IL-25 -induced endoplasmic reticulum stress in asthma. Sci Rep. 2018;8(1):7950. doi:10.1038/s41598-018-26221-x
   PubMed Web of Science ®Google Scholar
• Hesse L, Van ieperen N, Habraken C, et al. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model. Allergy. 2018;73(4):862–874. doi:10.1111/all.13382
   PubMed Web of Science ®Google Scholar
• Hoshino M, Akitsu K, Kubota K. Effect of sublingual immunotherapy on airway inflammation and airway wall thickness in allergic asthma. J Allergy Clin Immunol Pract. 2019;7(8):2804–2811. doi:10.1016/j.jaip.2019.06.003
   PubMed Web of Science ®Google Scholar
• Zissler UM, Jakwerth CA, Guerth F, et al. Allergen-specific immunotherapy induces the suppressive secretoglobin 1A1 in cells of the lower airways. Allergy. 2021;76(8):2461–2474. doi:10.1111/all.14756
   PubMed Web of Science ®Google Scholar
• Wawrzyniak M, Groeger D, Frei R, et al. Spermidine and spermine exert protective effects within the lung. Pharmacol Res Perspect. 2021;9(4):e00837. doi:10.1002/prp2.837
   PubMed Web of Science ®Google Scholar
• Sussan TE, Gajghate S, Chatterjee S, et al. Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function. Am J Physiol Lung Cell Mol Physiol. 2015;309(1):L27–36. doi:10.1152/ajplung.00398.2014
   PubMed Web of Science ®Google Scholar
• Angelina A, Martin-Fontecha M, Ruckert B, et al. The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption. Allergy. 2021;76(6):1900–1902. doi:10.1111/all.14707
   PubMed Web of Science ®Google Scholar
• Evans MJ, Van Winkle LS, Fanucchi MV, Plopper CG. Cellular and molecular characteristics of basal cells in airway epithelium. Exp Lung Res. 2001;27(5):401–415. doi:10.1080/019021401300317125
   PubMed Web of Science ®Google Scholar
• Hewitt RJ, Lloyd CM. Regulation of immune responses by the airway epithelial cell landscape. Nat Rev Immunol. 2021;21(6):347–362. doi:10.1038/s41577-020-00477-9
   PubMed Web of Science ®Google Scholar
• Yang Y, Riccio P, Schotsaert M, et al. Spatial-temporal lineage restrictions of embryonic p63(+) progenitors establish distinct stem cell pools in adult airways. Dev Cell. 2018;44(6):752–761 e754. doi:10.1016/j.devcel.2018.03.001
   PubMed Web of Science ®Google Scholar
• Morrisey EE. Basal cells in lung development and repair. Dev Cell. 2018;44(6):653–654. doi:10.1016/j.devcel.2018.03.004
   PubMed Web of Science ®Google Scholar
• Jakiela B, Brockman-Schneider R, Amineva S, Lee WM, Gern JE. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol. 2008;38(5):517–523. doi:10.1165/rcmb.2007-0050OC
   PubMed Web of Science ®Google Scholar
• Bukowy-Bieryllo Z. Long-term differentiating primary human airway epithelial cell cultures: how far are we? Cell Commun Signal. 2021;19(1):63. doi:10.1186/s12964-021-00740-z
   PubMed Web of Science ®Google Scholar
• Knoop KA, Newberry RD. Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol. 2018;11(6):1551–1557. doi:10.1038/s41385-018-0039-y
   PubMed Web of Science ®Google Scholar
• Rogers DF. The airway goblet cell. Int J Biochem Cell Biol. 2003;35(1):1–6. doi:10.1016/S1357-2725(02)00083-3
   PubMed Web of Science ®Google Scholar
• Rogers DF. Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? Clin Exp Allergy. 2002;32(8):1124–1127. doi:10.1046/j.1365-2745.2002.01474.x
   PubMed Web of Science ®Google Scholar
• Jackson AD. Airway goblet-cell mucus secretion. Trends Pharmacol Sci. 2001;22(1):39–45. doi:10.1016/S0165-6147(00)01600-X
   PubMed Web of Science ®Google Scholar
• Yang S, Yu M. Role of goblet cells in intestinal barrier and mucosal immunity. J Inflamm Res. 2021;14:3171–3183. doi:10.2147/JIR.S318327
   PubMedGoogle Scholar
• Rokicki W, Rokicki M, Wojtacha J, Dzeljijli A. The role and importance of club cells (Clara cells) in the pathogenesis of some respiratory diseases. Kardiochir Torakochirurgia Pol. 2016;13(1):26–30. doi:10.5114/kitp.2016.58961
   PubMedGoogle Scholar
• Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy. 2000;30(4):469–475. doi:10.1046/j.1365-2222.2000.00760.x
   PubMed Web of Science ®Google Scholar
• Wang SX, Liu P, Wei MT, et al. Roles of serum Clara cell protein 16 and surfactant protein-D in the early diagnosis and progression of silicosis. J Occup Environ Med. 2007;49(8):834–839. doi:10.1097/JOM.0b013e318124a927
   PubMed Web of Science ®Google Scholar
• Pilon AL. Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease. Ann N Y Acad Sci. 2000;923:280–299. doi:10.1111/j.1749-6632.2000.tb05536.x
   PubMed Web of Science ®Google Scholar
• Tata PR, Mou H, Pardo-Saganta A, et al. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature. 2013;503(7475):218–223. doi:10.1038/nature12777
   PubMed Web of Science ®Google Scholar
• Morimoto M, Nishinakamura R, Saga Y, Kopan R. Different assemblies of Notch receptors coordinate the distribution of the major bronchial Clara, ciliated and neuroendocrine cells. Development. 2012;139(23):4365–4373. doi:10.1242/dev.083840
   PubMed Web of Science ®Google Scholar
• Guseh JS, Bores SA, Stanger BZ, et al. Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. Development. 2009;136(10):1751–1759. doi:10.1242/dev.029249
   PubMed Web of Science ®Google Scholar
• Thomas B, Rutman A, Hirst RA, et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol. 2010;126(4):722–729 e722. doi:10.1016/j.jaci.2010.05.046
   PubMed Web of Science ®Google Scholar
• Tilley AE, Walters MS, Shaykhiev R, Crystal RG. Cilia dysfunction in lung disease. Annu Rev Physiol. 2015;77:379–406. doi:10.1146/annurev-physiol-021014-071931
   PubMed Web of Science ®Google Scholar
• Van Lommel A. Pulmonary neuroendocrine cells (PNEC) and neuroepithelial bodies (NEB): chemoreceptors and regulators of lung development. Paediatr Respir Rev. 2001;2(2):171–176. doi:10.1053/prrv.2000.0126
   PubMedGoogle Scholar
• Noguchi M, Furukawa KT, Morimoto M. Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease. Dis Model Mech. 2020;13:12. doi:10.1242/dmm.046920
   Web of Science ®Google Scholar
• Kobayashi Y, Tata PR. Pulmonary neuroendocrine cells: sensors and sentinels of the lung. Dev Cell. 2018;45(4):425–426. doi:10.1016/j.devcel.2018.05.009
   PubMed Web of Science ®Google Scholar
• Johnson DE, Georgieff MK. Pulmonary neuroendocrine cells. Their secretory products and their potential roles in health and chronic lung disease in infancy. Am Rev Respir Dis. 1989;140(6):1807–1812. doi:10.1164/ajrccm/140.6.1807
   PubMed Web of Science ®Google Scholar
• Sui P, Wiesner DL, Xu J, et al. Pulmonary neuroendocrine cells amplify allergic asthma responses. Science. 2018;360:6393. doi:10.1126/science.aan8546
   Web of Science ®Google Scholar
• Goldfarbmuren KC, Jackson ND, Sajuthi SP, et al. Dissecting the cellular specificity of smoking effects and reconstructing lineages in the human airway epithelium. Nat Commun. 2020;11(1):2485. doi:10.1038/s41467-020-16239-z
   PubMed Web of Science ®Google Scholar
• Montoro DT, Haber AL, Biton M, et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature. 2018;560(7718):319–324. doi:10.1038/s41586-018-0393-7
   PubMed Web of Science ®Google Scholar
• Plasschaert LW, Zilionis R, Choo-Wing R, et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature. 2018;560(7718):377–381. doi:10.1038/s41586-018-0394-6
   PubMed Web of Science ®Google Scholar
• Ruan YC, Wang Y, Da Silva N, et al. CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway. J Cell Sci. 2014;127(Pt 20):4396–4408. doi:10.1242/jcs.148098
   PubMed Web of Science ®Google Scholar
• Shah VS, Meyerholz DK, Tang XX, et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science. 2016;351(6272):503–507. doi:10.1126/science.aad5589
   PubMed Web of Science ®Google Scholar
• Vieira Braga FA, Kar G, Berg M, et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med. 2019;25(7):1153–1163. doi:10.1038/s41591-019-0468-5
   PubMed Web of Science ®Google Scholar
• Deprez M, Zaragosi LE, Truchi M, et al. A single-cell atlas of the human healthy airways. Am J Respir Crit Care Med. 2020;202(12):1636–1645. doi:10.1164/rccm.201911-2199OC
   PubMed Web of Science ®Google Scholar
• Schneider C, O’Leary CE, Locksley RM. Regulation of immune responses by tuft cells. Nat Rev Immunol. 2019;19(9):584–593. doi:10.1038/s41577-019-0176-x
   PubMed Web of Science ®Google Scholar
• Krasteva G, Canning BJ, Hartmann P, et al. Cholinergic chemosensory cells in the trachea regulate breathing. Proc Natl Acad Sci U S A. 2011;108(23):9478–9483. doi:10.1073/pnas.1019418108
   PubMed Web of Science ®Google Scholar
• O’Leary CE, Schneider C, Locksley RM. Tuft cells-systemically dispersed sensory epithelia integrating immune and neural circuitry. Annu Rev Immunol. 2019;37:47–72. doi:10.1146/annurev-immunol-042718-041505
   PubMed Web of Science ®Google Scholar
• Kohanski MA, Workman AD, Patel NN, et al. Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018;142(2):460–469 e467. doi:10.1016/j.jaci.2018.03.019
   PubMed Web of Science ®Google Scholar
• Patel NN, Kohanski MA, Maina IW, et al. Solitary chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2018;8(8):900–906. doi:10.1002/alr.22142
   Web of Science ®Google Scholar